3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 1
2
Phase NA
1
Phase 3
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
3
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Triple Negative Breast Neoplasms
1
Neoplasms
1
Malignant Tumor of Pancreas Metastatic to Liver
1
Cholangiocarcinoma
1
Interventions
Gemcitabine
5
Cisplatin
5
pembrolizumab
2
Photochemotherapy
2
futibatinib
1
Taxes
1
Radiofrequency Ablation
1
Paclitaxel
1
Neoadjuvant Therapy
1
Lasers
1
Fulvestrant
1
Drug Therapy
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
1-phenyl-3,3-dimethyltriazene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Cholangiocarcinoma
×
Albumin-Bound Paclitaxel
×
Clear all
NCT06037980
2025-02-17
PURITY
Gruppo Oncologico del Nord-Ovest
Phase 2/3
Recruiting
300 enrolled